Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study.
Journal:
European journal of nuclear medicine and molecular imaging
PMID:
37606859
Abstract
OBJECTIVE: To develop and independently externally validate robust prognostic imaging biomarkers distilled from PET images using deep learning techniques for precise survival prediction in patients with diffuse large B cell lymphoma (DLBCL).